Viskase Holdings Inc 's Revenue in the fiscal year 2025 $ 1.92 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2024 $ 0.03 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2023 $ 2.26 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2022 $ 0.03 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2021 $ 0.70 millions
ENZN Revenue second quarter 2026 Y/Y Growth Comment
Viskase Holdings inc achieved in the second quarter 2026, above Company average Revenue surge of 17926.2% year on year, to $ 90.13 millions.
Among companies who have reported second quarter 2026 results in the Biotechnology & Pharmaceuticals industry only one Company has achieved higher year on year Revenue results in the second quarter 2026. While Viskase Holdings Inc ' s Revenue doubling of 17926.2% ranks overall at the positon no. 11 in the second quarter 2026.
ENZN Revenue ( Y/Y Growth %)
2026
2025
2024
2023
4th Quarter
December
-
-
-
2033.33 %
3rd Quarter
September
-
-23.08 %
4.84 %
-
2nd Quarter
June
17926.2 %
1566.67 %
-94.55 %
-
1st Quarter
March
17100 %
-23.08 %
44.44 %
-
FY
-
45.11 %
-41.15 %
-
Financial Statements
Viskase Holdings Inc 's second quarter 2026 Revenue
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Viskase Holdings Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
20040.52 %
512.4 %
-100 %
(Mar 31 2026)
ENZN's II. Quarter Q/Q Revenue Comment
Viskase Holdings inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.8% quarter on quarter, to $ 90.13 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0% in the II. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Viskase Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1165.
Viskase Holdings inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.8% quarter on quarter, to $ 90.13 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0% in the II. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Viskase Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1165.
Viskase Holdings Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 177.05
$ 87.42
$ 1.92
$ 2.04
$ 2.20
Y / Y Revenue Growth (TTM)
-
4973.94 %
2.56 %
3.76 %
13.65 %
Year on Year Revenue Growth Overall
Ranking
#
# 2667
# 2056
# 1051
# 3670
Seqeuential Revenue Change (TTM)
102.52 %
4450.96 %
-5.83 %
-7.19 %
27.57 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 10
# 2667
# 2056
# 1051
# 3670
Cumulative Revenue growth Comment
Viskase Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 17926.2% year on year, to $ 177 millions if the fiscal year would have ended in Jun 30 2026. Viskase Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 171.55% and higher than 4973.94% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 102.52 % from $87.42 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at171.55%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 102.52 % increase from $87.42 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Healthcare sector 218 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 10, from total ranking in previous quarter at 2667.
Viskase Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 17926.2% year on year, to $ 177 millions if the fiscal year would have ended in Jun 30 2026. Viskase Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 171.55% and higher than 4973.94% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 102.52 % from $87.42 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at171.55%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 102.52 % increase from $87.42 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Healthcare sector 218 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 10, from total ranking in previous quarter at 2667.
About Viskase Holdings Inc Revenue Growth Rates (ENZN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
27,694.64%